On 31 January 2023, the EU Clinical Trial Regulation (CTR) will be applicable for new clinical trials with a medicinal product.
The CTR became applicable as of 31 Januari 2022. A transition period of three years started. During the first year, sponsors can choose to submit a clinical trial application according to the current legislation, or according to the CTR via CTIS. The first transition year ends on 30 January 2023, 00:00 hours.
More information on CTR for investigators can be found on de site of the CCMO: clinical-trials-with-medicinal-products-ctr